Publication | Closed Access
No Beneficial Effects of Human Growth Hormone Therapy in Normal Ovulatory Patients with a Poor Ovarian Response to Gonadotropins
13
Citations
0
References
1993
Year
Hormonal ContraceptiveFertilityPoor Ovarian ResponseHuman GrowthReproductive HealthGynecologyMenstrual CycleOvarian CancerIvf OutcomePublic HealthReproductive HormoneMenopause Hormone TherapyInfertilityGrowth HormoneEndocrinologyVitro FertilizationOvarian HormoneBeneficial EffectsHuman Growth HormoneMenopauseNormal Ovulatory PatientsMedicineWomen's Health
We studied the effects of human growth hormone (hGH) in 7 in vitro fertilization (IVF) patients with normal ovulatory menstrual cycles who showed a low response to ovarian stimulation with follicle-stimulating hormone (FSH) and human menopausal gonadotropin (hMG). Human growth hormone therapy had no significant effect on the number of days of gonadotropic stimulation, on the total amount of hMG administered, on the serum estradiol level on the day of human chorionic gonadotropin injection, or on the IVF outcome. Our preliminary results do not encourage the routine use of hGH to improve IVF outcome in normogonadotropic ovulatory patients who respond poorly to the standard FSH/hMG protocol.